LIXT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lixte Biotechnology Holdings Inc (LIXT) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, there are no significant trading trends, no positive news catalysts, and the financial performance shows significant losses. While the stock has a chance of minor short-term gains, it does not align with the user's long-term investment goals.
The MACD is negative and expanding downward (-0.00567), RSI is neutral at 23.946, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 2.703 and resistance at 3.191.
NULL identified. There is no recent news or significant insider/hedge fund activity.
and a decline in EPS (-25% YoY). Technical indicators are bearish, and there is no recent congress trading data or influential figure activity.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -$2,030,765 (up 105.95% YoY), and a drop in EPS to -0.33 (-25% YoY). Gross margin remains at 0%.
No analyst rating or price target data available.
